Hot Topics In - Forthcoming Issues

› Oral antiplatelet agents: new insights in managing patients with acute coronay syndromes

Bonaca MP, Giugliano RP (USA)

› The effect of n-3 fatty acids on lipids and lipoproteins in patients with renal disease if or not undergoing chronic haemodialysis: an overview of the current evidence of benefits and future opportunities

Svensson M, Hagstrup Christensen J (Denmark)

› Valsartan-based combination treatment, hydrochlorotiazide and amlodipine: where and when

Waeber B (Switzerland)

› Antihypertensive treatment by initial fixed dose combination of two drugs. Implications of the TALENT data

Mancia G (Italy)

› Breast cancer (Part One)

   - Management of patients with estrogen receptor-negative breast cancer     
     Andreopoulou E, Hortobagyi GN (USA)
   - Use of gene expression profiling in identifying patients at increased risk of recurrence and metastasis     
     Metzger Filho O, Bedard P, Ignatiadis M, Sotiriou C (Belgium)
     

› Optimizing bronchodilatation in COPD: is it possible?

  - Indacaterol, a novel long-acting bronchodilator for COPD
    Baloira Villar A (Spain)
  - How to obtain maximal bronchodilatation
    Cazzola M (Italy)
  - Clinical benefits of maximal bronchodilatation (part one)
    O'Donnell DE, Ora J, Laveneziana P (Canada)
  - Clinical benefits of maximal bronchodilatation (part two)
    Soler-Cataluña JJ, Martínez-García MA (Spain) 

› Influenza A (H1N1): the disease, its treatment and prevention

  - The epidemiology of influenza viruses in humans
    Fraaij PLA, Osterhaus A (Netherlands)
  - Clinical manifestations of influenza A
    Ramírez Venegas A, Pérez Bautista O, Sansores RH (México)
  - Influenza A. Prvention and treatment
    Rohde G (Netherlands)

› Clinical management of viral coinfections

  - Management of patients coinfected with HBV and HCV
    Potthoff A, Wedemeyer H (Germany)
  - Update on the HCV/HIV coinfection 
    Soriano V (Spain)
  - Current therapy of the HBV/HIV coinfection
    Rockstroh J (Germany)

› Multiple sclerosis: actual and prospective therapies

   - Interferon beta 1a in multiple sclerosis: effects, perspectives and dilemmas 
     Soelberg Sørensen P (Denmark)
   - Immunomodulatory therapies and Glatiramer acetate. A review of their use in multiple sclerosis
     Leussink VI, Stüve O, Meyer zu Hörste G, Kieseier BC (Germany)
   - Upcoming treatment options in relapsing remitting multiple sclerosis
     Putzki N, Limmroth V (Germany)
   - Oral therapies: fingolimodand cladribine
     Hartung HP (Germany)

› Epilepsy and antiplatelet drugs

   - Epilepsy in the elderly: therapeutical choices
     Arain A (USA)
   - Status epilepticus in elderly: therapeutical choices
     Kanner AM (USA)
   - Seizure and epilepsy after ischemic stroke
     Vercueil L (France)